GH Research (GHRS) Receivables - Other (2023 - 2025)

GH Research's (GHRS) quarterly Receivables - Other came in at $1.2 million in Q4 2025, down 26.8% year-on-year from $1.6 million in Q4 2024, and down 26.8% quarter-over-quarter from $1.6 million in Q4 2024.

GH Research (GHRS) Receivables - Other (2023 - 2025) Analysis & Trends

GH Research's Receivables - Other history runs 3 years deep, the most recent figure standing at $1.2 million for Q4 2025.

  • On a quarterly basis, Receivables - Other fell 26.8% year-over-year to $1.2 million in Q4 2025; TTM through Dec 2025 was $1.2 million, a 26.8% decrease from a year earlier, with the FY2025 full-year figure at $1.2 million, down 26.8% from the prior year.
  • Receivables - Other slipped to $1.2 million in Q4 2025 per GHRS's latest filing, from $1.6 million in the prior quarter.
  • Across five years, Receivables - Other topped out at $1.6 million in Q4 2024 and bottomed at $119000.0 in Q4 2023.
  • The 3-year median for Receivables - Other is $1.2 million (2025), against an average of $953000.0.
  • Across the five-year window, Receivables - Other soared 1229.41% in 2024 and slipped 26.8% in 2025, its largest moves.
  • Year by year, Receivables - Other stood at $119000.0 in 2023, then surged by 1229.41% to $1.6 million in 2024, then retreated by 26.8% to $1.2 million in 2025.
  • Per Business Quant, the three latest GHRS Receivables - Other figures stand at $1.2 million (Q4 2025), $1.6 million (Q4 2024), and $119000.0 (Q4 2023).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 GH Research 1.69 Bn 1.69 Bn -

Historic Data

Download Data
DateValue
Dec 31, 2025 1.16 Mn
Dec 31, 2025 1.16 Mn
Dec 31, 2024 1.58 Mn
Dec 31, 2024 1.58 Mn
Dec 31, 2023 119,000.00
Dec 31, 2023 119,000.00